Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20


Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.

Woo YS, McIntyre RS, Kim JB, Lee MS, Kim JM, Yim HW, Jun TY.

Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):391-401. doi: 10.9758/cpn.2017.15.4.391.


A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.

Coplan JD, Gopinath S, Abdallah CG, Berry BR.

Front Behav Neurosci. 2014 May 20;8:189. doi: 10.3389/fnbeh.2014.00189. eCollection 2014. Review.


Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Drozda K, Müller DJ, Bishop JR.

Pharmacotherapy. 2014 Feb;34(2):166-84. doi: 10.1002/phar.1398. Review.


Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.

Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM.

Pharmgenomics Pers Med. 2012;5:19-35. doi: 10.2147/PGPM.S23462. Epub 2012 Jan 13.


Structure-function associations in hippocampus in bipolar disorder.

Chepenik LG, Wang F, Spencer L, Spann M, Kalmar JH, Womer F, Kale Edmiston E, Pittman B, Blumberg HP.

Biol Psychol. 2012 Apr;90(1):18-22. doi: 10.1016/j.biopsycho.2012.01.008. Epub 2012 Feb 10.


Possible manic switch induced by combination of bupropion and electroconvulsive therapy in recurrent unipolar depression: a case series.

Saddichha S, Soy A, Vibha P.

BMJ Case Rep. 2009;2009. pii: bcr06.2008.0107. doi: 10.1136/bcr.06.2008.0107. Epub 2009 Feb 26.


Pharmacogenetics of antidepressant response.

Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A.

J Psychiatry Neurosci. 2011 Mar;36(2):87-113. doi: 10.1503/jpn.100059. Review.


The neurobiology of the switch process in bipolar disorder: a review.

Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA Jr.

J Clin Psychiatry. 2010 Nov;71(11):1488-501. doi: 10.4088/JCP.09r05259gre. Epub 2010 May 4. Review.


Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

Luddington NS, Mandadapu A, Husk M, El-Mallakh RS.

Prim Care Companion J Clin Psychiatry. 2009;11(3):93-102.


The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.

Mundo E, Cattaneo E, Zanoni S, Altamura AC.

Neuropsychiatr Dis Treat. 2006 Jun;2(2):139-48.


Pharmacogenetics of antidepressant response: an update.

Drago A, De Ronchi D, Serretti A.

Hum Genomics. 2009 Apr;3(3):257-74. Review.


Pharmacogenomic strategy for individualizing antidepressant therapy.

Lin KM, Perlis RH, Wan YJ.

Dialogues Clin Neurosci. 2008;10(4):401-8. Review.


How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR.

Neuropharmacology. 2008 Nov;55(6):932-60. doi: 10.1016/j.neuropharm.2008.08.034. Epub 2008 Sep 11. Review.


A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.

Weinberger AH, Vessicchio JC, Sacco KA, Creeden CL, Chengappa KN, George TP.

J Clin Psychopharmacol. 2008 Oct;28(5):584-7. doi: 10.1097/JCP.0b013e318184ba3c. No abstract available.


Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Lotrich FE, Pollock BG.

Neuropsychiatr Dis Treat. 2005 Mar;1(1):17-35.


Pharmacogenetics in mood disorder.

Nnadi CU, Goldberg JF, Malhotra AK.

Curr Opin Psychiatry. 2005 Jan;18(1):33-9.


Pharmacogenetics in drug development.

McCarthy AD, Kennedy JL, Middleton LT.

Philos Trans R Soc Lond B Biol Sci. 2005 Aug 29;360(1460):1579-88. Review.


Genetics and psychopharmacology: prospects for individualized treatment.

Nnadi CU, Goldberg JF, Malhotra AK.

Essent Psychopharmacol. 2005;6(4):193-208. Review.

Supplemental Content

Support Center